Protalex Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.13 |
Market Cap |
$1.54 M |
Shares Outstanding |
47.33 M |
Public Float |
6.15 M |
Address |
131 Columbia Turnpike Florham Park New Jersey 07932 United States |
Employees | - |
Website | http://www.protalex.com |
Updated | 07/08/2019 |
Protalex, Inc. is a development stage company which focuses on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis. Its product includes PRTX-100, formulated with purified staphylococcal protein A, which is an immune modulating protein produced by bacteria. The company was founded by John E. |